The differences between the Federal Circuit’s most-reversed and least-reversed district courts run far deeper than their success rates on appeal — a metric that can vary widely throughout the judiciary, according to Law360’s look at three years of Federal Circuit cases.
In a decision that could represent the final blow to an aggressive licensing program by LG Electronics, a federal judge in Northern California has thrown out the Korean electronics maker’s four-year patent lawsuit against U.S. and Taiwanese makers of computers and motherboards.
Biotech company Chiron has sued Seattle startup Corus Pharma, which is preparing to go public, for allegedly misappropriating trade secrets underpinning the development of an inhalable drug for cystic fibrosis.
A federal judge has thrown out Pinpoint’s patent lawsuit against Amazon.com, Borders Group and other online retailers, but said the company could refile the lawsuit if it ensures that the patents are properly assigned.
A panel of judges at the U.S. Court of Appeals for the Federal Circuit in Washington D.C. is scheduled to hear an appeal this week of a lower court’s decision to order Microsoft Corp. to pay $565 million in damages for infringing a patent with its Internet Explorer web browser.
A U.S. appeals court in Washington, D.C. has rejected Mylan Laboratories' bid to market a generic version of Johnson & Johnson's Duragesic pain-relief skin patch.
Akamai Technologies Inc. has agreed to a cash settlement in its long-standing dispute with a bankrupt unit of Cable & Wireless over patents for content delivery technology, the Cambridge, Massachusetts-based company said.
Commerce One, a bankrupt California software company with patent rights to a number of key technical protocols for online commerce, sold its intellectual property portfolio for $15.5 million to a mysterious bidder at Monday’s closely watched auction at the U.S. Bankruptcy Court for the Northern District of California in San Francisco.
Chicago-based intellectual property specialty firm McAndrews, Held & Malloy has expanded its staff with six more associates, bringing the firm’s size to more than 90 attorneys and nine technology specialists.
Piper Rudnick’s merger with the British law firm DLA will create one of the world’s largest intellectual property practices, with well over 200 attorneys dedicated to IP.
In a victory for Samsung Electronics, LG Electronics, Orion Electronic and Hyundai Electronics, South Korea’s Supreme Court has nullified a patent for a plasma display panel (PDP) awarded to Japanese electronics giant Fujitsu in 1995.
Auto parts maker Remy International has sued three more companies for patent infringement, shortly after settling two other patent lawsuits and dropping a third.
Real estate franchise RE/MAX International, Inc. has settled its trademark lawsuit against online mortgage broker LendingTree, Inc., the two companies said.
A Florida restaurant chain that features female staff dressed in skimpy outfits did not infringe on the trade dress of the Hooters chain, a federal judge has ruled.
The ink has barely dried on Australia’s free trade agreement with the U.S., yet U.S. trade officials are already warning that its trading partner may face a legal challenge over laws designed to help generic competition to brand-name drugs.
A German court has ruled for Energizer Holding’s Schick unit in rival Gillette Co.’s patent infringement lawsuit over the company’s four-bladed Quattro razor.
Japan’s first private patent search company, founded by industrial giants including automaker Toyota, plans to start operations on April 1st of next year.
Three years after Barr Laboratories Inc. successfully challenged the patent on Eli Lilly’s blockbuster antidepressant Prozac, the company has set its sights on the patent for Lilly’s new top-selling drug, the anti-psychotic Zyprexa.
Another generic drug maker has launched a challenge against the patent for Shire Pharmaceuticals Group PLC’s Adderall XR, a blockbuster drug for the treatment of attention deficit and hyperactivity disorders.
In a stinging setback for Boston Scientific Corp., a federal judge has held that the medical device maker violated its agreements with Israel’s Medinol Ltd. when it set up a secret stent-making operation in Ireland in 1997.
A federal judge has tentatively approved a $75 million settlement agreement between GlaxoSmithKline PLC and a group of consumers and third-party payors who claimed the U.K. drug maker broke antitrust law by trying to block generic competition for the arthritis drug Relafen.